Services

Master Plan of Action for the Second Term MNMP

Plan of action is prepared for the explanation of strategies about the policy planning. The Second Term MNMP Master Plan of Action is formulated following the Second Term MNMP. This document contains detailed information about the implementation timeline, indicator, target and related stakeholders for each activity and strategy in the policy.

MNMP First Term Performance Report

A term performance report is produced as an evaluation to the MNMP. The First Term Performance Report of the MNMP consists of the achievements for the initiatives implemented based on the plan of action of MNMP ranged from 2007 until 2011. The report also showed the gaps and challenges, and identified the future direction of the pharmaceutical sector in holding firm to the objective of the policy.

Penalty

Any individual who commits an offence under Control Of Drugs and Cosmetics Regulations 1984 can be fined up to a maximum of RM25,000 or a jail sentence not exceeding 3 years or both for the first offence, and for a subsequent offence, a fine up to a maximum of RM50,000 or a jail sentence not exceeding 5 years or both.

Hence, beware when buying medicines via the Internet. Check before you click!

Enforcement action

In order to protect the health and welfare of the public, the enforcement in online sales of pharmaceutical products through the internet has become a major challenge to the Pharmaceutical Services Division, Ministry of Health Malaysia. This Division is trying to curb the selling of pharmaceutical products which violate the provisions of law detected in the digital medium.

Tips on how to buy medicines online

Below are the tips on how to buy medicines online safely:

How to recognize approved advertisement?

 

All advertisements approved by Medicines Advertisement Board (MAB) will be given approval numbers. The approval number begins with KKLIU, followed by 4 digits referring to the serial number and ends with year which refers to when the approval is submitted. Each approval number must be displayed on the published advertisement. Consumers are adviced not to be confused between MAL registration number with the serial number KKLIU approval.

Illegal Advertisement: Don’t Get Influenced

Most of the advertisements frequently used superlative words or phrases such as ‘Guaranteed’, ‘Effective’, ‘No side effect’, Miracle’, No. 1’ and many others. And surprisingly, many of the advertisements promise something that is dubious. Sometimes many of these illegal advertisements displayed immoral statement especially those relating with sexual performance. For example, improving sexual function either directly or implied for the purpose of getting public attraction.

Risk of purchasing medications via Internet

Health-related technology is undergoing a transformation driven by Internet domination in everyday life. The results of these technological developments can be seen through the development of activities and advertisements related to health. The ability of people to surf the internet such as blogs and social media in a variety of mediums provide opportunity for certain groups of people to promote and influence the public in making choices related to health products.

AWARENESS CAMPAIGN - BUYING MEDICINES ONLINE: BEWARE

Waspada pembelian ubat "online"

AWARENESS CAMPAIGN - BUYING MEDICINE ONLINE: BEWARE

This campaign is aimed at giving consumer awareness regarding the risks of buying medicines online as many online consumers may not be aware of the risks. Let's download the poster and share with your friends and family. To get more information, guidance, e-posters, and videos please click the following image:

Malaysian National Medicines Policy (MNMP) First Term

The MNMP is executed in term. The First Term MNMP covers a period of 5 years from year 2007 until 2011. The policy resulted from the collaborative effort among government agencies and private sector. Consultations with the aid from the World Health Organization (WHO) through workshops and meetings with all stakeholders produced the policy document in year 2006 and succeeded by endorsement from the Malaysian Cabinet as an official national pharmaceutical policy.

The First Term MNMP comprises of eight components as followed:

Four core components:

Pages